Non-ischaemic titrated cardiac injury caused by radiofrequency catheter ablation of atrial fibrillation mobilizes CD34-positive mononuclear cells by non-stromal cell-derived factor-1alpha mechanism by 박희남
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Aims It has been known that myocardial ischaemia mobilizes CD34þ bone marrow-derived cells by the stromal cell-
derived factor (SDF)-1a pathway. We hypothesized that non-ischaemic titrated cardiac injury caused by radiofre-
quency catheter ablation (RFCA) of atrial fibrillation (AF) recruits CD34þ cells by an alternative mechanism.
Methods
and results
Fifty-six patients (39 males, 53.0+13.5 years old) who underwent electrophysiology study (EPS; n ¼ 10) or RFCA of
AF (n ¼ 46) were included. Peripheral blood CD34þ cell count and multiple serologic markers were evaluated
before, immediately after, at 24 h, and 10 days after the procedure. The results are as follows: (i) the per cent increase
in CD34þ cells (%DCD34þ) was significant after RFCA compared with after EPS (P, 0.01), and correlated with RF
duration and troponin I, respectively. (ii) In contrast, SDF-1a decreased after RFCA and had no correlation
with %DCD34þ cells while matrix metalloproteinase (MMP)-9 (P, 0.0001) and GROb (P, 0.001) increased
after RFCA and had correlations with 24 h %DCD34þ cells.
Conclusion Non-ischaemic titrated cardiac injury caused by AF ablation mobilizes CD34þ cells to the peripheral blood through a
non-SDF-1a pathway associated with MMP-9 and GROb.
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Introduction
It has been reported that endothelial progenitor cells can be iso-
lated from circulating mononuclear cells1–3 and bone marrow.4
These cells express a number of endothelial cell surface markers
and exhibit endothelial properties.1,3 Circulating endothelial pro-
genitor cells increase after vascular injury,5,6 acute myocardial
infarction,5 and percutaneous coronary intervention7 by stromal
cell-derived factor (SDF)-1a.8 –12 Although there are significant
differences in critical mass and tissue characteristics between ven-
tricles and atria, Goette et al.13 reported an increase in
haematopoietic progenitor cells immediately after electrical cardi-
oversion of atrial fibrillation (AF) related to SDF-1a. GRObD4 also
mobilizes peripheral blood mononuclear cells by a mechanism less
dependent on the SDF-1a/CXCR4 axis,14 but is related to
angiopoietin-1 and MMP-9.15–17 Most studies of CD34þ cell
mobilization have been related to myocardial ischaemia or endo-
thelial function. Mobilization of circulating CD34þ mononuclear
cells by non-ischaemic titrated cardiac injury has not been pre-
viously reported. The radiofrequency catheter ablation (RFCA)
technique is an effective rhythm control strategy for AF.18 There-
fore, we hypothesized that non-ischaemic titrated cardiac injury
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caused by AF ablation can recruit CD34þ cells. The purpose of
this study was to investigate the mechanism of the peripheral
blood CD34þ cell mobilization after AF ablation and to determine
its effects on the outcome of the ablation procedure.
Methods
Patient selection
Fifty-six patients (39 males, 53.0+13.5 years old) who underwent
electrophysiology study (EPS) (n ¼ 10) or RFCA for AF [n ¼ 46; par-
oxysmal AF (PAF):persistent AF (PeAF) ¼ 26:20] were included in this
study. In 10 patients who underwent EPS, we used basic programmed
stimulation but did not perform RFCA. In 46 patients with AF, a mean
of 1.8+ 1.4 antiarrhythmic drugs were proven to be ineffective. The
mean left atrial (LA) size measured by echocardiography was 42.2+
7.2 mm and did not show structural heart disease, except for left ven-
tricular hypertrophy. Three-dimensional (3D) computed tomography
(CT) scans were performed to visually define the anatomy of the pul-
monary veins (PVs). The presence of LA thrombus was excluded by
transoesophageal echocardiography. All antiarrhythmic drugs were dis-
continued for a period corresponding to at least five half-lives. Amio-
darone was discontinued for at least 4 weeks. Anticoagulation therapy
was continued until the day of the procedure.
Electrophysiological mapping
The study protocol was approved by the Institutional Review Board of
Anam Hospital, Korea University, and adhered to the declaration of
Helsinki. All patients provided written informed consent. Intracardiac
electrograms were recorded using a Prucka CardioLabTM electrophysi-
ology system (General Electric Medical Systems, Inc., Milwaukee, WI,
USA). For the EPS group (n ¼ 10), we used three mapping catheters
and performed basic EPS by programmed stimulation. Atrial and ven-
tricular stimulation protocols were conducted without RF energy
delivery. For the AF RFCA group (n ¼ 46), we used five mapping cath-
eters and a 7 Fr deflectable 3.5 mm tip open irrigation tip ablation
catheter (Celsius, Johnson & Johnson Inc., Diamond Bar, CA, USA)
and catheter ablation procedures were performed using a 3D electro-
anatomical mapping system (NavX; St Jude Medical Inc., Minneapolis,
MN, USA) in all patients. If the initial rhythm was AF lasting .5 min,
AF was terminated by internal cardioversion (2, 5, 7, to 10 J serially,
depending on the result of cardioversion, biphasic shocks with
R-wave synchronization, anodal decapolar catheter in the high right
atrium to cathodal duodecapolar catheter inside of the coronary
sinus. Lifepak12, Physiocontrol Ltd). Immediately after cardioversion,
the earliest atrial premature beat initiating AF was mapped as we
described previously.19 Before catheter ablation, we generated a 3D
LA electroanatomical map and voltage map by contact bipolar electro-
grams from 70–100 points in the LA endocardium during high right
atrial pacing (cycle length, 500 ms). The voltage map was colour
coded. Atrial fibrillation ablation was performed at the level of the
LA antrum without touching the PV directly.
Radiofrequency catheter ablation
Radiofrequency applications (30 W, 478C, irrigation flow rate
20–30 mL/min, 40 s of RF delivery at each ablation point, Stockert
generator, Biosense Webster Inc., Diamond Bar, CA, USA) were per-
formed with a 7 Fr deflectable 3.5 mm tip open irrigation tip catheter
(Celsius, Johnson & Johnson Inc.). Electrical isolation of all four PVs and
circumferential antral ablation were performed in all patients. Cavotri-
cuspid isthmus block and linear ablation of the left lateral isthmus, LA
roof, and septum were carried out in patients with PeAF, depending on
AF inducibility in those with PAF. The total procedure time, fluoro-
scopic time, duration of RF energy delivery, and non-ablation pro-
cedure time (total procedure time2 ablation time) were counted in
all patients. After the procedure, patients were followed without anti-
arrhythmic medications and asked to visit the outpatient clinic at 1, 3,
6, 9, and 12 months, and every 6 months thereafter. Electrocardiogra-
phy (ECG) was performed at every visit or anytime the patient
reported palpitations. Holter ECG (24 or 48 h) and/or event recorder
was evaluated at 3, 6, and 12 months after RFCA.
Protocol for quantification of CD341
mononuclear cells
Peripheral blood samples were taken before, immediately after, at
24 h, and 10 days after the procedure to quantify CD34þ haemato-
poietic progenitor cells and biochemical analyses. Peripheral blood
circulating CD34þ mononuclear cell count was measured by a
fluorescence-activated cell sorter (FACS) within 4 h of sampling.
Flow cytometry was done using a monoclonal antibody to CD34
(Becton–Dickinson, Heidelberg, Germany). The Stem-Kit Reagents
(Beckman–Coulter, USA) utilized a calibrated number of fluorescent
beads with direct quantification of CD34þ cell concentration.
Samples were gated to the CD45þ population from which CD34þ
cells were identified. The cut-off point for CD34 positivity was deter-
mined from isotype-matched antibodies.
Biochemical analyses
We measured serum levels of SDF-1a, granulocyte colony-stimulating
factor (G-CSF), GRO-b, MMP-9, and angiopoietin-1 using ELISA kits
(R&D Systems, Minneapolis, MN, USA) to evaluate the mechanism
of haematopoietic progenitor cell mobilization after non-ischaemic
cardiac injury. Serum concentration of troponin I at 24 h after RFCA
was also quantified by the Vitros ECiQ (OCD, Johnson & Johnson,
Holmers Farm Way, UK) method to estimate the degree of cardiac
injury.
Analyses of left atrial electroanatomic
voltage map
To quantify the degree of atrial substrate remodelling, we analysed the
colour-coded LA electroanatomical voltage maps as reported pre-
viously.20,21 Both anterior–posterior and posterior–anterior views
of each map were captured and converted to image files. All of the
colour voltage images were divided into four quadrants, and the per-
centages of each colour were measured and calculated. Pulmonary
veins were not included in the analysis. The percentage of colour-
coded areas in each quadrant (eight quadrants per patient) of
voltage maps was analysed by custom software (Image Pro) and refer-
enced to colour scale bars. The NavX system detected peak-to-peak
voltage differences in each contact bipolar electrogram and changed
them to colour codes. Low-voltage areas ,0.2 mV were coded grey
and high-voltage areas 1.0 mV were purple. The mean LA voltage
was calculated by summation of per cent area of each colour multiplied
by representative voltage, and then divided by the total LA area.
Data analyses
We analysed the per cent change in CD34þ (%DCD34þ) cell count
and serum levels of protein biological markers according to time
sequence before and after EPS or RFCA. Left atrial size, the mean
LA voltage, total duration of RF energy delivery, non-ablation pro-
cedure time, and incidence of recurrence of AF after ablation were
compared with %DCD34þ cells and biological markers. Data are



















expressed as mean+ standard deviation (SD). Linear correlation,
Student’s t-test, and Fisher’s exact test were used for analyses of com-
parisons. A P-value of ,0.05 was considered statistically significant.
Results
Non-ischaemic titrated cardiac injury
by radiofrequency catheter ablation
mobilizes peripheral blood CD341
mononuclear cells
The %DCD34þ cells were significantly elevated immediately
(60.2+ 87.3%, P, 0.001) and 24 h after AF ablation (59.4+
112.6%, P, 0.001), and remained increased for 10 days after
RFCA (58.7+ 130.8%, P, 0.01). They were also significantly elev-
ated after RFCA for AF compared with after EPS (Figure 1). We
compared %DCD34þ cells instead of absolute cell count
because FACS was performed within 4 h of blood sampling and
reset the control value in each blood sample. The total duration
of RF energy delivery, the specific marker for cardiac injury (tropo-
nin I), and %DCD34þ cells were correlated with one other with
statistical significance (Figure 2A–C ). However, non-ablation pro-
cedure time (total procedure time2 total duration of RF ablation)
and fluoroscopic time were not associated with %DCD34þ cells
(P ¼ NS; Figure 2D and E). We delivered 2.85+2.46 times of low-
energy internal cardioversion shocks (total shock, 2.85+20.32 J)
during the procedure, but they did not have a correlation with
post-ablation %DCD34þ cells (P ¼ NS). Post-ablation absolute
CD34þ cell count (1.99+1.09 vs. 3.59+ 3.40/mL, P ¼ NS) and
%DCD34þ cells (49.2+86.1 vs. 57.1+ 103.1%, P ¼ NS) were
not significantly different with (n ¼ 35) or without low-energy
electrical cardioversion (n ¼ 11).
CD341 cell mobilization after
non-ischaemic titrated cardiac injury
by non-stromal cell-derived factor-1a
mechanism
To estimate the mechanism of CD34þ mononuclear cell mobiliz-
ation, we quantified the serial change of SDF-1a, G-CSF,
angiopoietin-1, MMP-9, and GROb. Stromal cell-derived
factor-1a, which plays a role in the mobilization of CD34þ cells
after ischaemic cardiovascular injury, was not increased after
RFCA, but rather decreased at 24 h after RFCA (2.09+ 0.69–
1.60+ 0.43 ng/mL, P, 0.01; Figure 2E). Neither did G-CSF after
RFCA (7.88+ 13.64–9.50+16.02 mg/mL, P ¼ NS). In contrast,
both MMP-9 (39.97+ 26.34–119.65+71.42 ng/mL, P, 0.01)
and GROb (0.29+ 0.22–0.82+ 0.60 ng/mL, P, 0.01) were sig-
nificantly increased immediately after RFCA for AF (Figure 2F and
G). We compared the correlations between immediate post-
ablation plasma levels of each serologic marker to those related
to progenitor cell mobilization and %DCD34þ cells at 24 h after
RFCA. Although SDF-1a did not have any correlation with
%DCD34þ cells (Figure 3A), GROb (R ¼ 0.61, P, 0.001) and
MMP-9 (R ¼ 0.44, P, 0.01) had significant correlations with the
degree of CD34þ mononuclear cell mobilization (Figure 3B and
C ). GROb and MMP-9 may play a role in mononuclear cell mobil-
ization and homing as a non-SDF-1a alternative mechanism, and
Figure 1 (A) Flow cytometry detection of endothelial progenitor cells double-labelled with CD45 and CD34 detected in gate R4 by FACS.
(B) The %DCD34þ cells were significantly increased after RFCA immediately, at 24 h, and 10 days in patients with AF, and immediate and 24 h
post-ablation %DCD34þ cells were higher than after EPS. (C) Absolute CD34þ cell count showed a similar pattern of change to %DCD34þ
cells without statistical significance. *P, 0.01 vs. pre-ABL; #P, 0.01 vs. EPS.



















plasma levels of GROb and MMP-9 had a good correlation
(R ¼ 0.62, P, 0.01; Figure 3D).
Atrial fibrillation burden and mobilization
of CD341 cells
In terms of AF burden, we compared patients with PAF and PeAF
(Table 1). Patients with PeAF were older, had a larger LA size, and
received a longer duration of RFCA compared with those with
PAF. Pre-ablation absolute CD34þ cell count was not different
between patients with PAF and PeAF. In contrast, post-ablation
absolute CD34þ cell count was significantly higher in patients
with PeAF (P, 0.05, Figure 4A) who underwent a longer duration
of RF delivery (91.43+26.64 vs. 68.34+26.36 min, P, 0.01)
than in those with PAF. Because low LA voltage reflects long-
lasting AF with structural remodelling, we compared LA voltage
and %DCD34þ cells in 16 patients. Post-ablation %DCD34þ cell
count was significantly higher in patients with a mean
LA voltage ,2.3 mV (147.7+ 85.9%) than in those with a
mean LA voltage 2.3 mV (43.7+78.2%, P, 0.01, Figure 4C).
Both LA voltage (R ¼ 20.50, P, 0.05) and its heterogeneity
(SD of LA voltages in eight different segments of the LA;
R ¼ 20.65, P, 0.01) exhibited a negative correlation with post-
ablation %DCD34þ cells (Figure 4D and E).
Discussion
In this study, we documented the effects of non-ischaemic titrated
cardiac injury on the mobilization of bone marrow-derived
CD34þ mononuclear cells in peripheral blood after RFCA of
AF. We also suggest that the non-SDF-1a mechanism is associated
with MMP-9 and GROb in the mobilization of CD34þ cells after
RFCA. CD34þ cell mobilization was correlated with the duration
of RF delivery, amount of cardiac injury reflected by troponin I
levels, and more significant in patients with a mean LA voltage
2.3 mV than in those with a mean LA voltage ,2.3 mV.
Circulating CD341 mononuclear cells
and cardiovascular disease
Endothelial progenitor cells derived from bone marrow circulate in
peripheral blood and are involved in neoangiogenesis after tissue
ischaemia.1,22,23 These cells express a number of endothelial cell
surface markers, such as CD34þ, and exhibit endothelial proper-
ties.1,3 Circulating endothelial progenitor cells are capable of pro-
liferating and differentiating into endothelial cells and contribute to
vascular regeneration.24 In addition, they have been shown to
differentiate into cardiomyocytes and smooth muscle cells follow-
ing myocardial infarction.25 It has been reported that endothelial
progenitor cells are mobilized after acute myocardial infarction,5
Figure 2 The %DCD34þ cells correlated with non-ischaemic titrated cardiac injury after RFCA. (A) Correlation between %DCD34þ cells
and the total duration of RF energy delivery. (B) Correlation between %DCD34þ cells and the cardiac-specific injury marker troponin I. (C)
Correlation between RF duration and level of troponin I. (D and E) Non-ablation procedure time (total procedure time2 RF ablation time) or
fluoroscopic time did not have any correlation with %DCD34þ cells. (F) The plasma level of SDF-1a did not increase after RFCA for AF, but
rather decreased 24 h after RFCA. (G and H ) Both plasma levels of MMP-9 and GROb increased immediately after RFCA for AF. *P, 0.01.



















percutaneous coronary intervention,7 and microvascular angina.26
The level of circulating CD34þ endothelial progenitor cells has
been reported to be able to predict the occurrence of cardiovas-
cular events and death in patients with coronary artery disease.27
Theses findings suggest that CD34þ cells play an important role
in repair mechanisms after cardiac injury.28 However, most clinical
studies have been focused on myocardial ischaemia or vascular
injury. To the best of our knowledge, this study is the first to
prove non-ischaemic titrated cardiac injury-induced mobilization
of CD34þ progenitor cells in peripheral blood, even after exclud-
ing the effects of AF burden, internal electrical cardioversion, or
the non-ablation procedure itself.
Mechanism of CD341 mononuclear cell
mobilization after non-ischaemic cardiac
injury
The mechanism of endothelial progenitor cell mobilization after
cardiac injury remains elusive. There have been several reports
of potential biological messengers that induce mobilization or
homing of peripheral blood- or bone marrow-derived endothelial
progenitor cells. The chemokine SDF-1a has been shown to play a
key role in CD34þ trafficking in the myocardial ischaemia
model.9,11,29 However, SDF-1a was not elevated nor related to
CD34þ cell concentration in this study or other studies.30 The
mechanism for this result has yet to be clarified whether due to
counter-balanced SDF-1a by alternative pathway, difference
between ventricular tissue vs. atrial tissue, or ischaemic vs.
non-ischaemic cardiac injury. In contrast, MMP-9 and GROb
were elevated immediately after RFCA and had good correlations
with post-ablation 24 h %DCD34þ cells and to each other.
Angiopoientin-1 has been known to induce stoichiometric
changes in pro-MMP-9 and tissue inhibitor of metalloproteinase-1,
and activated MMP-9 enhances GROb/CXCR2 ligands that
promote mobilization of bone marrow-derived progenitor and
endothelial cells.14–17 Fukuda et al.14 reported that GRObD4
mobilizes peripheral blood mononuclear cells that adhere to vas-
cular cell adhesion molecule-1 and endothelial cells, and this
Figure 3 (A) Immediate post-ablation SDF-1a did not have a correlation with %DCD34þ cells at 24 h post-ablation. (B and C ) Immediate
post-ablation plasma levels of GROb and MMP-9 had weak correlations with 24 h post-RFCA %DCD34þ cells. (D) Post-ablation plasma levels
of GROb had correlations with those of MMP-9.



















Figure 4 (A) Comparison of PeAF and PAF over time and absolute CD34þ cell count. The increase in CD34þ mononuclear cells in per-
ipheral blood was significant after RFCA for PeAF, but not for PAF. Immediate post-ablation CD34þ cell count was also higher in patients with
PeAF than those with PAF. (B) Comparison of PeAF and PAF over time and %DCD34þ cells. (C ) Examples of colour voltage maps with low and
homogeneous LA voltage (upper panel) and high and heterogeneous LA voltage (lower panel). Left atrial voltage (D) and its spatial heterogen-
eity (E) had a negative correlation with the per cent change of CD34þ cells immediately after RFCA. *P, 0.05 vs. PAF; †P, 0.01 vs. pre-ABL.
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Table 1 Comparisons of clinical, electrophysiological, and biological parameters in patients with PAF vs. PeAF
PAF (n5 26) PeAF (n5 20) P-value
Sex (M:F) 17:9 17:3 NS
Age (years) 51.27+12.54 59.65+8.60 ,0.01
LA size (mm) 39.23+5.58 46.6+8.02 ,0.001
Ejection fraction (%) 53.42+12.25 55.29+5.53 NS
Mean LA voltage (mV) 6.75+5.00 6.39+4.43 NS
RF duration (min) 73.86+28.16 95.28+25.02 ,0.01
Conc. of CD34þ cells (per mL)
Pre-ABL 2.64+3.19 3.19+4.43 NS
Post-ABL 3.18+3.04 4.07+5.02 ,0.05
24 h 3.35+5.22 3.78+6.01 NS
10 days 2.74+3.49 4.77+10.15 NS
%DCD34þ cells (%)
Post-ABL 47.06+73.49 80.47+99.22 NS
24 h 55.96+82.62 73.0+151.05 NS
10 days 51.06+141.69 64.78+123.06 NS



















pathway is less dependent on the SDF-1a/CXCR4 axis. Therefore,
non-ischaemic titrated cardiac injury mobilizes peripheral blood
CD34þ mononuclear cells by non-SDF-1a mechanism in our clini-
cal study model.
CD341 mononuclear cells and atrial
fibrillation
Goette et al.13 reported that PeAF appears to be associated with
an increase in haematopoietic progenitor cells compared with
PAF and controls. In contrast, low-energy internal electrical
shocks did not affect CD34þ cell mobilization in our study. The
reasons for the discrepancies were likely due to differences in
clinical settings, lower energy used for electrical cardioversion,
and RF-induced direct cardiac tissue injury. Recently, Stein
et al.30 reported that RFCA for PV isolation did not mobilize
bone marrow-derived stem cells in patients with PAF. In their
study, progenitor cell response to RFCA was minimal and
delayed in patients with PAF as shown in Figure 4A. However,
RFCA increased %DCD34þ cells in patients with PeAF signifi-
cantly. The total duration of RF energy delivery was longer and
the increase in troponin level was higher in our study. We also
compared %DCD34þ cells instead of the absolute count of
CD34þ cells because all cell counts were measured within 4 h
of blood sampling and reset the control value in every FACS study.
Study limitations
We tested our hypothesis on a relatively small number of selected
patients who underwent RFCA. Because we performed RF energy
delivery by continuous ablation, we could not count the exact
number of RF lesions. Peripheral blood samples may not reflect
the remote non-ischaemic cardiac injury of the atria, which is
thinner and has a lower muscular mass than the ventricles.
Although CD34þ cells include various types of non-specific
bone marrow-derived cells, it reflects the cellular migration of
endothelial progenitor cells as reported in previous studies.5,7
Therefore, additional basic study analysing atrial tissue is warranted
to prove the mechanism of CD34þ cell mobilization after non-
ischaemic cardiac injury by RF energy delivery.
Conclusions
This is the first study to document the effects of non-ischaemic
titrated cardiac injury on the mobilization of CD34þ mononuclear
cells in peripheral blood after RFCA of AF. CD34þ cell mobiliza-
tion was correlated with the duration of RF delivery, amount of
cardiac injury measured by troponin I level, and low and hetero-
geneous LA voltage. The potential mechanism was non-SDF-1a,
non-G-CSF pathway, associated with MMP-9 and GROb. Further
study with a larger sample size will define the role of CD34þ
mononuclear cell mobilization in the clinical recurrence of AF or
long-term prognosis in patients who undergo RFCA.
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